1
Paul Edward Aldrich, Argyrios Georgios Arvanitis, Robert Scott Cheeseman, Robert John Chorvat, Thomas Eugene Christos, Paul Joseph Gilligan, Dimitri Emil Grigoriadis, Carl Nicholas Hodge, Paul John Krenitsky, Everett Latham Scholfield, Sang William Tam, Zelda Rakowitz Wasserman: 1N-alkyl-n-arylpyrimidinamines and derivatives thereof. DuPont Pharmaceuticals Company, Robert W Black, Kenneth B Rubin, Kalim S Fuzail, January 29, 2002: US06342503 (66 worldwide citation)

The present invention provides novel compounds, compounds and pharmaceutical compositions thereof, and methods of using same in the treatment of affective disorders, anxiety, depression, post-traumatic stress disorders, eating disorders, supranuclear palsy, irritable bowel syndrome, immune suppressi ...


2
Paul Edward Aldrich, Argyrios Georgios Arvanitis, Rajagopal Bakthavatchalam, James Peter Beck, Robert Scott Cheeseman, Robert John Chorvat, Paul Joseph Gilligan, Carl Nicholas Hodge, Zelda Rakowitz Wasserman: 1N-alkyl-N-arylpyrimidinamines and derivatives thereof. Dupont Pharmaceuticals Company, Monte R Browder, Kenneth B Rubin, August 22, 2000: US06107301 (58 worldwide citation)

The present invention provides novel compounds, compounds and pharmaceutical compositions thereof, and methods of using same in the treatment of affective disorders, anxiety, depression, post-traumatic stress disorders, eating disorders, supranuclear palsy, irritable bowel syndrome, immune suppressi ...


3
Liqi He, Paul Joseph Gilligan, Argyrios Georgios Arvanitis, Robert John Chorvat: Azolo triazines and pyrimidines. Dupont Pharmaceuticals Co, Maureen O Brien, Kenneth B Rubin, September 26, 2000: US06124289 (21 worldwide citation)

Corticotropin releasing factor (CRF) antagonists of formula I or II: ##STR1## and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivityassociated with psych ...


4

5
Parthasarathi Rajagopalan, Robert John Chorvat, Rajagopal Bakthavatchalam, James Peter Beck, Paul Joseph Gilligan, Richard Eric Olson: 6-aryloxy and arylthiopurines. DuPont Pharmaceuticals Company, Kenneth B Rubin, Kalim S Fuzail, July 10, 2001: US06258809 (12 worldwide citation)

Novel compounds and pharmaceutical compositions thereof, and methods of using same in treating anxiety, depression, and other psychiatric and neurological disorders. The novel compounds provided by this invention are those of the following formulae:


6
Parthasarathi Rajagopalan, Robert John Chorvat, Rajagopal Bakthavatchalam, James Peter Beck, Paul Joseph Gilligan, Richard Eric Olson: Aryloxy- and arylthio- fused pyridines and pyrimidines and derivatives. DuPont Pharmaceuticals, Maureen P O Brien, Kenneth B Rubin, September 26, 2000: US06124300 (10 worldwide citation)

Novel compounds and pharmaceutical compositions thereof, and methods of using same in treating anxiety, depression, and other psychiatric and neurological disorders. The novel compounds provided by this invention are those of the following formulae: ##STR1## wherein R.sup.1, R.sup.13, X, Y, Z, G and ...


7
Rajagopal Bakthavatchalam, Argyrios Georgios Arvanitis, James Peter Beck, Gary Avonn Cain, Robert John Chorvat, Paul Joseph Gilligan, Richard Eric Olson: Arylamino fused pyrimidines. Dupont Pharmaceuticals, Don M Kerr, August 22, 2000: US06107300 (10 worldwide citation)

Corticotropin releasing factor (CRF) antagonists of formula I or formula II: ##STR1## and their use in treating anxiety, depression, and other psychiatric and neurological disorders.


8
John Francis McElroy, Robert John Chorvat: Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes. Jenrin Discovery, Vance Intellectual Property PC, January 27, 2009: US07482470 (8 worldwide citation)

The present invention provides novel pyrazoles that are useful as cannabinoid receptor antagonists and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, and/or cardiometabolic disorders.


9
John Francis McElroy, Robert John Chorvat: Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers. Jenrin Discovery, Vance Intellectual Property PC, March 25, 2014: US08680131 (1 worldwide citation)

The present invention provides novel, diastereomeric pyrazolines that are useful as cannabinoid receptor blockers and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, inflammatory disorders, cardiometabolic disorders, hepatic disorders, and/or cancers ...


10
Robert John Chorvat, Parthasarathi Rajagopalan: Aryloxy- and arylthiosubstituted pyrimidines and triazines and derivatives thereof. DuPont Pharmaceuticals Company, Gerald J Boudreaux, Kenneth B Rubin, Kalim S Fuzail, December 4, 2001: US06326368 (1 worldwide citation)

The present invention provides novel compounds, and pharmaceutical compositions thereof, and methods of using same in the treatment of affective disorders, anxiety, depression, post-traumatic stress disorders, eating disorders, supranuclear palsey, irritable bowl syndrome, immune supression, Alzheim ...



Click the thumbnails below to visualize the patent trend.